Come up with a name for your new list and we'll add to it:
PDS Biotechnology raised a round of funding on March 03, 2010. Investors include
National Cancer Institute.
PDS Biotechnology is a clinical stage biopharmaceutical company developing simpler, safer and more effective immunotherapies for cancer and infectious disease. PDS Biotechnology has developed a novel …